Pfizer and Merck Covid-19 antiviral pills receive FDA emergency use authorization
Pfizer and Merck have now both received emergency use authorization for their Covid-19 antiviral pills. The U.S. Government purchased a combined 13.1 million courses of both company's antiviral pills for $7.49 billion. The pharmaceutical giants are expected to begin shipping each drug soon.
Thu, Dec 23 20214:30 PM EST